Loading articles...
CardiomyopathiesESC Cardio-Oncology 2026: Key Sessions and Anticipated Focus Areas
The ESC Cardio-Oncology 2026 congress will address cardiotoxicity from cancer therapies, focusing on early detection and management strategies.
Valvular Heart DiseasesZurich Heart Surgery Scandal: Device Safety Alert Issued
A safety alert has been issued regarding cardiac devices used in Zurich, prompting concerns about patient outcomes and regulatory oversight.
Heart FailureSerum Potassium Concentrations Shape Heart Failure Risk
Optimal serum potassium concentrations in heart failure (HF) are unclear, with new data clarifying the safe range for HFrEF and HFpEF.
Heart FailureManaging Acute Heart Failure And Cardiogenic Shock
Acute decompensated heart failure drives over one million hospital admissions annually. 30-day readmission rates are 25%. When the heart cannot compensate, the tools change entirely - IV diuretics, inotropes, mechanical circulatory support. Sarah Mitchell a...
Heart FailureSemaglutide For Obese Heart Failure Patients
More than 80% of HFpEF patients are overweight or obese. STEP-HFpEF showed semaglutide 2.4mg improved symptoms by 16 points on the KCCQ and reduced weight by 13.3% - now a Class IIa ESC recommendation. Sarah Mitchell and James Carter explore why treating th...
Heart FailureDiabetes Drugs For Stiff Heart Failure
Heart failure with preserved ejection fraction accounts for more than half of all HF diagnoses. For two decades every major drug trial failed. Then SGLT2 inhibitors changed everything - twice. Sarah Mitchell and James Carter explain why HFpEF was so hard, a...
Heart FailureHow Four Drugs Beat Heart Failure
Four drug classes — ARNi, beta-blocker, MRA, SGLT2 inhibitor — have together produced a 73% reduction in cardiovascular death and hospitalisation versus placebo in HFrEF. Sarah Mitchell and James Carter unpack why each drug works, what the landmark trials s...
Heart FailureTricuspid Valve Surgery Benefits Adults with Systemic Right Ventricle
Adults with transposition of the great arteries (TGA) and systemic morphologic right ventricle (SRV) often develop SRV failure and tricuspid regurgitation (TR). A new study investigates the impact of tricuspid valve surgery (TVS) on clinical outcomes in thi...
Coronary Artery DiseaseDual Plane Block May Cut Opioid Use After Bypass Surgery
A dual plane block technique for coronary artery bypass grafting (CABG) may reduce postoperative opioid consumption.
Heart FailurePAHO's HEARTS 2.0 Outlines 38-Step Pathway for Cardio-Renal Care
The PAHO HEARTS 2.0 initiative provides a 38-step pathway for integrated cardio-renal care, addressing the complex interplay of cardiovascular and kidney diseases.